Effectiveness and Safety Study of the DexCom™ G4 Continuous Glucose Monitoring System in Children and Adolescents With Type 1 Diabetes Mellitus
NCT01185496 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 64
Last updated 2011-06-13
Summary
The purpose of this study is to evaluate the safety and effectiveness of the G4 System when worn for up to 7-days by children and adolescent subjects (6 to \<18 years-old) with type 1 diabetes mellitus.
Conditions
Sponsors & Collaborators
-
DexCom, Inc.
lead INDUSTRY
Eligibility
- Min Age
- 6 Years
- Max Age
- 17 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2010-08-31
- Primary Completion
- 2010-10-31
- Completion
- 2010-11-30
Countries
- United States
Study Locations
More Related Trials
-
Continuous Glucose Monitoring in Adolescents With Poorly Controlled Type 1 Diabetes
NCT01586065 ·Status: COMPLETED ·Phase: NA
-
Glycemic Profiles And Insulin Delivery Across The Menstrual Cycle In Women With Type 1 Diabetes
NCT04665999 ·Status: COMPLETED
-
Diabeloop for Teens
NCT04725591 ·Status: COMPLETED ·Phase: NA
-
CGM Treatment in Patients With Type 1 Diabetes Treated With Insulin Injections
NCT02092051 ·Status: COMPLETED ·Phase: NA
-
Safety and Feasibility Study of the Eddii Mobile Application
NCT05205876 ·Status: COMPLETED ·Phase: NA
-
Timing of Initiation of Continuous Glucose Monitoring in Established Pediatric Diabetes (The CGM TIME Trial)
NCT01295788 ·Status: COMPLETED ·Phase: NA
-
Evaluation of the Omnipod DASH in Children and Adolescents With Type 1 Diabetes Mellitus
NCT05377385 ·Status: COMPLETED
-
New Glucose Sensor Pediatric
NCT01161043 ·Status: COMPLETED ·Phase: NA
-
Trial of Early Initiation of CGM-Guided Insulin Therapy in Stage 2 T1D
NCT04335513 ·Status: UNKNOWN ·Phase: NA
-
Closing the Loop 24/7 in Adolescents With Type 1 Diabetes
NCT01873066 ·Status: COMPLETED ·Phase: NA
-
Efficacy of Continuous Glucose Monitoring in Subjects With Type 1 Diabetes Mellitus on Multiple Daily Injections (MDI) or Continuous Subcutaneous Insulin Infusion (CSII) Therapy
NCT01104142 ·Status: COMPLETED
-
Prevalence of Nocturnal Hypoglycemia in Children on a Type 1 Diabetes (TID) Insulin Regimen Using a Continuous Glucose Monitoring System (CGMS)
NCT00542334 ·Status: COMPLETED
-
Pilot Study of Remote Glucose Monitoring Among Pediatric Patients With Type 1 Diabetes
NCT04696640 ·Status: COMPLETED ·Phase: NA
-
Automated Closed-loop in Children and Adolescents With Type 1 Diabetes
NCT02129868 ·Status: COMPLETED ·Phase: NA
-
A Study of the Safety, Tolerability, Pharmacokinetics and Pharmacodynamic Activity of Very Low Dose-Glucagon in Subjects With Type 1 Diabetes Mellitus
NCT00304538 ·Status: COMPLETED ·Phase: PHASE1
-
Safety Evaluation of MiniMed™ 780G System With DS5 CGM in Children
NCT06604871 ·Status: COMPLETED ·Phase: NA
-
Prospective Randomized Clinical Trial Assessing the Short Term Clinical Impact of Continuous vs Flash Glucose Monitoring in Children, Adolescents and Young Adults With Type 1 Diabetes
NCT04249102 ·Status: UNKNOWN ·Phase: NA
-
Closing the Loop in Children and Adolescents With Type 1 Diabetes in the Home Setting
NCT01778348 ·Status: COMPLETED ·Phase: PHASE2
-
Four-Week SkinSiteStudy in Type 1 Diabetes
NCT06177054 ·Status: COMPLETED ·Phase: NA
-
FreeStyle Libre FGM During Summer Camp for Children With Type 1 Diabetes
NCT03182842 ·Status: COMPLETED ·Phase: NA
-
Observational, Data Collection Study for Subjects With Diabetes Using Insulin Injections
NCT04013919 ·Status: UNKNOWN
-
Safety Evaluation of the Hybrid Closed Loop (HCL) System in Pediatric Subjects With Type 1 Diabetes
NCT02660827 ·Status: COMPLETED ·Phase: NA
-
Hypoglycemia at Initiation of Pump Therapy in Children With Type 1 Diabetes
NCT01840358 ·Status: UNKNOWN ·Phase: NA
-
Mini-Dose Glucagon to Treat Non-Severe Hypoglycemia
NCT02411578 ·Status: COMPLETED ·Phase: PHASE2
-
Glucose Counterregulation in Long Standing Type 1 Diabetes
NCT01474889 ·Status: COMPLETED ·Phase: NA